Nanovectorization of DNA Through Cells Using Protamine Complexation

被引:5
作者
Boukari, Khaoula [1 ]
Caoduro, Cecile [1 ]
Kacem, Raoudha [1 ]
Skandrani, Nadia [1 ]
Borg, Christophe [3 ]
Boulahdour, Hatem [1 ]
Gharbi, Tijani [1 ]
Delage-Mourroux, Regis [2 ]
Hervouet, Eric [2 ]
Pudlo, Marc [4 ]
Picaud, Fabien [1 ]
机构
[1] Univ Bourgogne Franche Comte, CHU UFR SMP, UFR Sci & Tech, Nanomed Imagery & Therapeut Lab,EA 4662, 19 Rue Ambroise Pare, F-25030 Besancon, France
[2] Univ Franche Comte, Express Genique & Pathol Syst Nerveux Cent, Lab Biochim, EA3922,SFRIBCT FED 4234,UFR Sci & Tech, Besancon, France
[3] Univ Bourgogne Franche Comte IFR133, EFS Bourgogne Franche Comte, Inserm 1098, Besancon, France
[4] Univ Bourgogne Franche Comte, EA Fonct & Dysfonct Epitheliales 4267, UFR Sci Med & Pharmaceut, 19 Rue Ambroise Pare, F-25030 Besancon, France
关键词
Nanovectorization; Protamine; Simulation; WALLED CARBON NANOTUBES; DRUG-DELIVERY VEHICLES; IN-VITRO; TRANSLOCATION; THERAPEUTICS; FUNCTIONALIZATION; ORGANIZATION; DOXORUBICIN; CHALLENGES; MEMBRANES;
D O I
10.1007/s00232-016-9890-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Carbon nanotubes (CNT) are currently used as a promising family of nanovectors able to deliver different types of therapeutic molecules. Several applications dealing with CNT used as drug nanocarriers have been developed since their ability to penetrate into the cells has been proved. CNT can thus load several active molecules to various cells. In this paper, we will use molecular dynamic simulation to describe theoretically the potential of CNT to transport and deliver DNA through the formation of protamine-DNA-CNT complex.
引用
收藏
页码:493 / 501
页数:9
相关论文
共 53 条
[1]   On modeling biomolecular-surface nonbonded interactions: application to nucleobase adsorption on single-wall carbon nanotube surfaces [J].
Akdim, B. ;
Pachter, R. ;
Day, P. N. ;
Kim, S. S. ;
Naik, R. R. .
NANOTECHNOLOGY, 2012, 23 (16)
[2]   Multiwalled carbon nanotube-doxorubicin supramolecular complexes for cancer therapeutics [J].
Ali-Boucetta, Hanene ;
Al-Jamal, Khuloud T. ;
McCarthy, David ;
Prato, Maurizio ;
Bianco, Alberto ;
Kostarelos, Kostas .
CHEMICAL COMMUNICATIONS, 2008, (04) :459-461
[3]   The protamine family of sperm nuclear proteins [J].
Balhorn, Rod .
GENOME BIOLOGY, 2007, 8 (09)
[4]   Carbon nanotubes as vectors for gene therapy: Past achievements, present challenges and future goals [J].
Bates, Katie ;
Kostarelos, Kostas .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (15) :2023-2033
[5]   Distribution and clearance of PEG-single-walled carbon nanotube cancer drug delivery vehicles in mice [J].
Bhirde, Ashwin A. ;
Patel, Sachin ;
Sousa, Alioscka A. ;
Patel, Vyomesh ;
Molinolo, Alfredo A. ;
Ji, Youngmi ;
Leapman, Richard D. ;
Gutkind, J. Silvio ;
Rusling, James F. .
NANOMEDICINE, 2010, 5 (10) :1535-1546
[6]   Targeted Killing of Cancer Cells in Vivo and in Vitro with EGF-Directed Carbon Nanotube-Based Drug Delivery [J].
Bhirde, Ashwin A. ;
Patel, Vyomesh ;
Gavard, Julie ;
Zhang, Guofeng ;
Sousa, Alioscka A. ;
Masedunskas, Andrius ;
Leapman, Richard D. ;
Weigert, Roberto ;
Gutkind, J. Silvio ;
Rusling, James F. .
ACS NANO, 2009, 3 (02) :307-316
[7]   Applications of carbon nanotubes in drug delivery [J].
Bianco, A ;
Kostarelos, K ;
Prato, M .
CURRENT OPINION IN CHEMICAL BIOLOGY, 2005, 9 (06) :674-679
[8]   The probable structure of the protamine-DNA complex [J].
Biegeleisen, Ken .
JOURNAL OF THEORETICAL BIOLOGY, 2006, 241 (03) :533-540
[9]   RNAi therapeutics: a potential new class of pharmaceutical drugs [J].
Bumcrot, David ;
Manoharan, Muthiah ;
Koteliansky, Victor ;
Sah, Dinah W. Y. .
NATURE CHEMICAL BIOLOGY, 2006, 2 (12) :711-719
[10]   DNA nanotechnology of carbon nanotube cells: physico-chemical models of self-organization and properties [J].
Buzaneva, E ;
Karlash, A ;
Yakovkin, K ;
Shtogun, Y ;
Putselyk, S ;
Zherebetskiy, D ;
Gorchinskiy, A ;
Popova, G ;
Prilutska, S ;
Matyshevska, O ;
Prilutskyy, Y ;
Lytvyn, P ;
Scharff, P ;
Eklund, P .
MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS, 2002, 19 (1-2) :41-45